FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlcidion Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
ALC.AX
Alcidion Group Limited Stock AnalysisComprehensive stock analysis for Alcidion Group Limited (ALC.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALC.AX
ALC.AX
Alcidion Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
ALC.AX
  1. Home
  2. Stocks
  3. Alcidion Group Limited

Alcidion Group Limited

🇦🇺ALC.AX•ASX

Alcidion Group Limited

🇦🇺ALC.AX•ASX
P/E ratio
70.44

Your view on ALC.AX

P/E
70.44
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alcidion Group Limited

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Kate Quirke
Headquarters
9 Yarra Street, South Yarra, VIC, AU
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Kate Quirke
Headquarters
9 Yarra Street, South Yarra, VIC, AU
Description

Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom.

Its flagship product, Miya Precision, is a consolidated platform built on the Fast Healthcare Interoperability Resources (FHIR) standard, aimed at enabling intelligent healthcare delivery.

The company also supplies Smartpage, a mobile and web-based system designed to streamline hospital communications and task management for clinical and administrative personnel.

Additional solutions include Patientrack, a tool for real-time patient monitoring and risk screening; Silverlink, which handles patient administration; and ExtraMed, software dedicated to optimizing clinical and patient flow.

Furthermore, Alcidion provides a range of services encompassing product deployment, support and maintenance, systems integration, and data analysis. Founded in 2000 and headquartered in South Yarra, Australia, the company was formerly known as Alcidion Corporation Pty Ltd until its rebranding as Alcidion Group Limited in December 2015.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Alcidion Group Limited from FRC's valuation model, read against the market price. ALC.AX last traded at AUD 0.09, 70.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Alcidion Group Limited. Starting points for Alcidion Group Limited: P/E 70.4, EPS AUD 0.02, beta 1.08 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Alcidion Group Limited. Alcidion Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Alcidion Group Limited. Trailing twelve-month EPS for Alcidion Group Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.01AUD 0.01AUD 0.02AUD 0.03
Lowest estimateAUD 0.01AUD 0.01AUD 0.02AUD 0.02
Highest estimateAUD 0.01AUD 0.01AUD 0.03AUD 0.05
Number of analysts1133
A year ago−AUD 0.011−AUD 0.001AUD 0.021—
Growth vs a year ago————

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 27.25MAUD 27.30MAUD 51.80MAUD 55.73M
Lowest estimateAUD 27.25MAUD 27.30MAUD 48.97MAUD 52.23M
Highest estimateAUD 27.25MAUD 27.30MAUD 56.69MAUD 67.98M
Number of analysts1145
A year agoAUD 17.64MAUD 23.15MAUD 51.64M—
Growth vs a year ago+54.5%+17.9%+0.3%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Alcidion Group Limited. Alcidion Group Limited has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ALC.AX20 companies
Compare ALC.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AYA.AXArtrya LimitedHealthcareMedical - Healthcare Information Services—
BMT.AXBeamtree Holdings LimitedHealthcareMedical - Healthcare Information Services—
ENL.AXEnlitic, Inc.HealthcareMedical - Healthcare Information Services—
ONE.AXOneview Healthcare PLCHealthcareMedical - Healthcare Information Services—
PCK.AXPainChek LimitedHealthcareMedical - Healthcare Information Services—
PKY.AXPathkey.AI LtdHealthcareMedical - Healthcare Information Services—
PME.AXPro Medicus LimitedHealthcareMedical - Healthcare Information Services—
RHT.AXResonance Health LimitedHealthcareMedical - Healthcare Information Services—
More Medical - Healthcare Information Services companies
TickerTypeCompanySectorExchangeMkt cap
EWLLeWellness Healthcare CorporationHealthcareOTC$185,077
FRLIFrélii, Inc.HealthcareOTC$5,347
GDRXGoodRx Holdings, Inc.HealthcareNASDAQ$1.1B
HCATHealth Catalyst, Inc.HealthcareNASDAQ$98.2M
HCTIHealthcare Triangle, Inc.HealthcareNASDAQ$2.4M
HDVYHealth Discovery CorporationHealthcareOTC$41,171
HIQ.AXHITIQ LimitedHealthcareASX—
HNGEHinge Health, Inc.HealthcareNYSE$9.3B
HQYHealthEquity, Inc.HealthcareNASDAQ$8.0B
HSTMHealthStream, Inc.HealthcareNASDAQ$831.6M
HTFLHeartflow, Inc. Common StockHealthcareNASDAQ$4.0B
IBXGiBX Group, Inc.HealthcareOTC$1,975
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Alcidion Group Limited.

ALC.AX AnalysisGood
Past
4
Growth
4
Health
5
Profit
1
Value
1